Medical Device Network on MSN2d
Neuromod secures €10m to expand tinnitus treatment device’s availability
"Neuromod secures €10m to expand tinnitus treatment device’s availability" was originally created and published by Medical ...
MassDevice2d
Neuromod raises $10.9M to support neuromod for tinnitus
Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...
BioWorld2d
Neuromod raises €10M to widen tinnitus device reach
Neuromod Devices Ltd. raised €10 million (US$10.9 million) in financing to expand the reach of Lenire, which treats tinnitus.
Neuromod raises €10m to continue expansion of tinnitus treatment device in US and European markets
Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...
Independent.ie on MSN2d
‘We’re very much an Irish story all the way’ – Neuromod raises €10m to expand its tinnitus treatment
Irish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...
AdnKronos2d
Neuromod Closes €10 Million Financing to Accelerate Commercialisation
DUBLIN, March 11, 2025 /PRNewswire/ -- Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a €10 million equity financing to ...
Business Post2d
Irish medtech Neuromod raises €10m in Series B extension
Dublin-based company has developed an FDA-approved device called Lenire that is for use with patients suffering from tinnitus ...
Morningstar2d
Neuromod Closes €10 Million Financing to Accelerate Commercialisation
The financing was oversubscribed and was led by existing investors Fountain Healthcare Partners and Panakès Partners, backing Neuromod's mission to advance tinnitus care for patients globally.